Synthetic Biology grants in the United Kingdom

Closed

Supports United Kingdom large-team bioscience projects through collaborative grants for high-impact innovation.

Closed

Supports United Kingdom university spin-outs in frontier AI, engineering biology, and advanced materials manufacturing.

Closed

Supports early-career United Kingdom bioscientists with fellowships that build independent innovation leadership.

Closed

Supports United Kingdom teams through follow-on funding to move discovery innovation toward commercialization.

Closed

Funds UK-based organisations developing biosecurity innovations across biodetection, AI diagnostics, and non-pharmaceutical protective systems for national security.

Closed

Supports United Kingdom biosecurity teams with innovation in sensing, diagnostics, and preventive systems.

Closed

Supports United Kingdom innovators building systems to detect and respond to biological risk faster.

Closed

Funds teams delivering high impact prototypes with milestone support for DASA Themed Competition Biosecurity Frontiers in defense innovation, biotechnology, and synthetic biology.

Closed

Supports DASA Themed Competition Future proofing Biosecurity Microbial Forensic Capability for practical innovation and measurable results.

Closed

Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.

Discontinued

Funds United Kingdom technology ventures across broad sectors through competitive grants for deep technology and innovation.

Open

Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.

Open

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.

Open

Funds two €5M projects turning marine organisms — algae, fungi, invertebrates — into safer bio-based replacements for adhesives, coatings and chemicals.

Open

Funds one €20M innovation project that scales alternative proteins, oils, fibres or specialty carbohydrates into safe, accepted food ingredients.

Open

Funds one €20M project that turns bio-based chemicals and ingredients into safer, sustainable home and personal care products at industrial scale.

Open

Funds one €20M industrial project that scales biotechnology into sustainable biorefineries and market-ready bio-based products.

Open

Funds two €7M projects that turn farm, forestry, aquatic and urban bio-waste into market-ready chemicals, materials and ingredients.

Open

Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.

Open

Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.

Open

Funds a €3M project that reviews how synthetic biology could be misused for bioterrorism and pinpoints where monitoring and regulation fall short.

Scheduled

Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.

Between cycles

Funds late stage deep tech start ups and small businesses with combined non dilutive and growth support across technology fields.

Between cycles

Funds innovative SME-led international R&D consortia through the Eurostars Call 12 grant process.